Potent CYP17 inhibitors: Improved syntheses, pharmacokinetics and anti-tumor activity in the LNCaP human prostate cancer model

Venkatesh D. Handratta, Danijela Jelovac, Brian J. Long, Ritesh Kataria, Ivo P. Nnane, Vincent C.O. Njar, Angela M.H. Brodie

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Potent CYP17 inhibitors: Improved syntheses, pharmacokinetics and anti-tumor activity in the LNCaP human prostate cancer model'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds